Panjin Central Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Stroke2 trials
• Coronary artery disease1 trial
• Diabetic eye disease1 trial
• Heart failure1 trial
• High blood pressure1 trial
• Macular degeneration1 trial

Phase

• Phase 33 trials

Status

• Not yet recruiting3 trials
• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Beijing Tiantan Hospital1 trial
• China Medical University, China1 trial
• First Hospital of China Medical University1 trial
• Hoffmann-La Roche1 trial
• Tasly Pharmaceutical Group Co., Ltd1 trial

Running trials

• Recruiting

  Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre

  NCT07687186· Phase 3· Tasly Pharmaceutical Group Co., Ltd· Source

  Contact: Li Li

• Recruiting

  Polypills Approach for Multiple Cardiovascular Risk Factors

  NCT07679828· China Medical University, China· Source

  Contact: Qiong Zhang

• Not yet recruiting

  Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window

  NCT07476898· Phase 3· First Hospital of China Medical University· Source

  Contact: Zhuo Li

• Active, not recruiting

  Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)

  NCT06439576· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease1 recruiting
• Heart failure1 recruiting
• High blood pressure1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)

  NCT05439356· Phase 3· Beijing Tiantan Hospital· Source